ATE39245T1 - Beta-adrenergisch antagonistische verbindungen und derivate von beta-adrenergischen antagonisten. - Google Patents
Beta-adrenergisch antagonistische verbindungen und derivate von beta-adrenergischen antagonisten.Info
- Publication number
- ATE39245T1 ATE39245T1 AT84300651T AT84300651T ATE39245T1 AT E39245 T1 ATE39245 T1 AT E39245T1 AT 84300651 T AT84300651 T AT 84300651T AT 84300651 T AT84300651 T AT 84300651T AT E39245 T1 ATE39245 T1 AT E39245T1
- Authority
- AT
- Austria
- Prior art keywords
- beta
- adrenergy
- antagonist
- moiety
- sec
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/70—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/72—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms
- C07C235/74—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of a saturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/44—Iso-indoles; Hydrogenated iso-indoles
- C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
- C07D303/02—Compounds containing oxirane rings
- C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
- C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
- C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
- C07D303/22—Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
- C07D303/02—Compounds containing oxirane rings
- C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
- C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
- C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
- C07D303/24—Ethers with hydroxy compounds containing no oxirane rings with polyhydroxy compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Biophysics (AREA)
- General Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Epoxy Compounds (AREA)
- Indole Compounds (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US46349883A | 1983-02-03 | 1983-02-03 | |
| EP84300651A EP0117089B1 (de) | 1983-02-03 | 1984-02-02 | Beta-adrenergisch antagonistische Verbindungen und Derivate von beta-adrenergischen Antagonisten |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE39245T1 true ATE39245T1 (de) | 1988-12-15 |
Family
ID=23840308
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT84300651T ATE39245T1 (de) | 1983-02-03 | 1984-02-02 | Beta-adrenergisch antagonistische verbindungen und derivate von beta-adrenergischen antagonisten. |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP0117089B1 (de) |
| JP (1) | JPS59176236A (de) |
| AT (1) | ATE39245T1 (de) |
| DE (1) | DE3475615D1 (de) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2644697B1 (fr) * | 1989-03-24 | 1992-05-15 | Poudres & Explosifs Ste Nale | Composes anesthesiques a duree d'action controlee et compositions pharmaceutiques les contenant |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1253709A (en) * | 1968-05-22 | 1971-11-17 | Frosst & Co Charles E | Thiadiazole derivatives |
| DE1922003C3 (de) * | 1969-04-30 | 1979-10-11 | Boehringer Mannheim Gmbh, 6800 Mannheim | N-(3-Aryloxy-2-hydroxypropyl)-aminocarbonsäuren, deren Ester, Amide und Salze, Verfahren zur Herstellung dieser Verbindungen und deren Verwendung bei der Bekämpfung von Herzinsuffizienz |
| GB1550838A (en) * | 1972-12-15 | 1979-08-22 | Ici Ltd | Alkanolamine derivatives |
| HU170678B (de) * | 1973-12-20 | 1977-08-28 | ||
| SE8004088L (sv) * | 1980-06-02 | 1981-12-03 | Haessle Ab | Nya substituerade 3-fenoxi-l-alkoxikarbonylalkylamino-propanol-2-er med beta-receptorblockerande egenskaper samt forfarande for deras framstellning, farmaceutiska beredningar innehallande desamma och metod att ... |
| EP0045334B1 (de) * | 1980-08-04 | 1984-03-14 | Syva Company | Antigene Zusammensetzungen des Propranolols und Antikörper und Verfahren zu deren Verwendung |
| EP0053434B1 (de) * | 1980-11-28 | 1986-08-27 | American Hospital Supply Corporation | Verbindungen und Verfahren zur Behandlung oder Prophylaxe von Herzkrankheiten |
-
1984
- 1984-02-02 AT AT84300651T patent/ATE39245T1/de not_active IP Right Cessation
- 1984-02-02 DE DE8484300651T patent/DE3475615D1/de not_active Expired
- 1984-02-02 EP EP84300651A patent/EP0117089B1/de not_active Expired
- 1984-02-03 JP JP59017222A patent/JPS59176236A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JPS59176236A (ja) | 1984-10-05 |
| EP0117089B1 (de) | 1988-12-14 |
| EP0117089A1 (de) | 1984-08-29 |
| DE3475615D1 (en) | 1989-01-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE126232T1 (de) | Neue derivate von a-nor-3-carboxysteroiden. | |
| ES2106965T3 (es) | Nuevas 4-aza-5alfa-androstan-3-onas 7beta-sustituidas como inhibidores de 5alfa-reductasa. | |
| ES2065880T3 (es) | Proteina quimicamente modificada y obtencion de la misma. | |
| ATE229334T1 (de) | Verwendung von crf-antagonisten | |
| DE69115432D1 (de) | Kohlenwasserstofflösung von Alkylaluminoxanverbindungen | |
| ATE291011T1 (de) | Hemmung der raf-kinase unter verwendung von symmetrisch und unsymmetrisch substituierten harnstoffen | |
| EA199900936A1 (ru) | Фунгицидные трифторметилалкиламинотриазолопиримидины | |
| ES2106783T3 (es) | 1-benzopiran-4-onas y 2-amino-1,3-benzoxacin-4-onas antiarterosclerosis y antitromboticas. | |
| ATE65994T1 (de) | Insektentoetende pyrazoline. | |
| DE69313921D1 (de) | Neue 7-Beta-substituierte-4-Aza-5-Alpha-Cholestan-Onen als Inhibitoren 5-Alpha-Reduktases | |
| DE69133190D1 (de) | Herstellung von Polyamiden aus Omega-Aminonitrilen | |
| DE69006854D1 (de) | Anhaftende selbstverkapselnde spritzzusammensetzungen von bioregulatorischen agenzien. | |
| ES2052961T3 (es) | Compuestos de fosfonio con actividad biocida. | |
| DE68916847D1 (de) | Monopersulfate von Amino-(poly)percarbonsäuren. | |
| DE69013750D1 (de) | Antagonisten von excitatorischen Aminosäuren. | |
| DE69129930D1 (de) | Verfahren zur Herstellung der Elektrodenmetallisierung von einem Transistor | |
| FI903571A0 (fi) | Menetelmä farmaseuttisesti aktiivisten peptidien valmistamiseksi | |
| ATE39245T1 (de) | Beta-adrenergisch antagonistische verbindungen und derivate von beta-adrenergischen antagonisten. | |
| DE68927630D1 (de) | Analoge von Peptrolsubstraten | |
| ATE26581T1 (de) | Bismaleimid enthaltende hitzehaertbare zusammensetzungen und polymere. | |
| DE3689289D1 (de) | Stabilisierung von Polyolefinen. | |
| ATE69220T1 (de) | Sechsgliedrige heterocyclische derivate von n'substituiertenn,n'-diacylhydrazinen. | |
| ATE55620T1 (de) | Verfahren zur herstellung von interferon. | |
| DK552283A (da) | Pyrimidinonforbindelser | |
| ES2053579T3 (es) | Nuevas fenilureas. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |